142 related articles for article (PubMed ID: 32229701)
1. TNM 8th edition in thyroid cancer staging: is there an improvement in predicting recurrence?
Manzardo OA; Cellini M; Indirli R; Dolci A; Colombo P; Carrone F; Lavezzi E; Mantovani G; Mazziotti G; Arosio M; Lania AGA
Endocr Relat Cancer; 2020 Jun; 27(6):325-336. PubMed ID: 32229701
[TBL] [Abstract][Full Text] [Related]
2. Risk of Recurrence in Differentiated Thyroid Cancer: A Population-Based Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems.
Gan T; Huang B; Chen Q; Sinner HF; Lee CY; Sloan DA; Randle RW
Ann Surg Oncol; 2019 Sep; 26(9):2703-2710. PubMed ID: 30830539
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
4. Survival in differentiated thyroid carcinoma: Comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system.
Cavalheiro BG; de Matos LL; Leite AKN; Kulcsar MAV; Cernea CR; Kowalski LP
Head Neck; 2021 Oct; 43(10):2913-2922. PubMed ID: 34062032
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma.
Chen Z; Ruan J; Yao Y; Wen L; Mao Z; Chen S; Zhu H; Zhao Y; Li Z; Fahey TJ; Teng L; Wang W
Ann Surg Oncol; 2021 Oct; 28(11):6564-6571. PubMed ID: 33521903
[TBL] [Abstract][Full Text] [Related]
6. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
[No Abstract] [Full Text] [Related]
7. Comparison of long-term prognosis for differentiated thyroid cancer according to the 7th and 8th editions of the AJCC/UICC TNM staging system.
Kim K; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Ther Adv Endocrinol Metab; 2020; 11():2042018820921019. PubMed ID: 32489582
[TBL] [Abstract][Full Text] [Related]
8. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.
Shteinshnaider M; Muallem Kalmovich L; Koren S; Or K; Cantrell D; Benbassat C
Thyroid; 2018 Feb; 28(2):201-209. PubMed ID: 29256827
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer.
van Velsen EFS; Peeters RP; Stegenga MT; van Kemenade FJ; van Ginhoven TM; van Balkum M; Verburg FA; Visser WE
J Clin Endocrinol Metab; 2023 May; 108(6):e267-e274. PubMed ID: 36508298
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
11. Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).
Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
Clin Endocrinol (Oxf); 2019 Aug; 91(2):331-339. PubMed ID: 30525210
[TBL] [Abstract][Full Text] [Related]
12. Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM.
Sapuppo G; Grasso S; Di Benedetto G; Belfiore A; Pellegriti G
Front Endocrinol (Lausanne); 2023; 14():1128963. PubMed ID: 36992807
[TBL] [Abstract][Full Text] [Related]
13. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
14. A relook at the 8th edition of the AJCC TNM staging system of anaplastic thyroid carcinoma: A SEER-based study.
Xiang J; Wang Z; Sun W; Zhang H
Clin Endocrinol (Oxf); 2021 Apr; 94(4):700-710. PubMed ID: 33368530
[TBL] [Abstract][Full Text] [Related]
15. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
Chen LJ; Chang YJ; Chang YJ
Oncologist; 2021 Mar; 26(3):e445-e453. PubMed ID: 32969134
[TBL] [Abstract][Full Text] [Related]
16. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
[TBL] [Abstract][Full Text] [Related]
17. Modification of the Tumor-Node-Metastasis Staging System for Differentiated Thyroid Carcinoma by Considering Extra-Thyroidal Extension and Lateral Cervical Lymph Node Metastasis.
Kim M; Kim WG; Jeon MJ; Kim HK; Yi HS; Kim ES; Kim BH; Kim WB; Shong YK; Kang HC; Kim TY
Endocrinol Metab (Seoul); 2020 Mar; 35(1):149-156. PubMed ID: 32207275
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer.
Kim M; Kim WG; Oh HS; Park S; Kwon H; Song DE; Kim TY; Shong YK; Kim WB; Sung TY; Jeon MJ
Thyroid; 2017 Sep; 27(9):1149-1155. PubMed ID: 28635571
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of Lymph Node Ratio Integration with the 8
Lee J; Lee SG; Kim K; Yim SH; Ryu H; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS
Sci Rep; 2019 Sep; 9(1):13361. PubMed ID: 31527831
[TBL] [Abstract][Full Text] [Related]
20. Impact of the updated TNM staging criteria on prediction of persistent disease in a differentiated thyroid carcinoma cohort.
Nava CF; Zanella AB; Scheffel RS; Maia AL; Dora JM
Arch Endocrinol Metab; 2019 Feb; 63(1):5-11. PubMed ID: 30864625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
